Cargando…

High risk of renal dysfunction in patients with fulminant type 1 diabetes

AIMS/INTRODUCTION: To compare the incidence rate of renal dysfunction between patients with fulminant type 1 diabetes and those with acute‐onset type 1 diabetes. MATERIALS AND METHODS: The present retrospective cohort study included patients with fulminant type 1 diabetes and acute‐onset type 1 diab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Nobuyuki, Tsujimoto, Tetsuro, Chujo, Daisuke, Kajio, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754524/ https://www.ncbi.nlm.nih.gov/pubmed/28267278 http://dx.doi.org/10.1111/jdi.12652

Ejemplares similares

Short‐term changes in pancreatic α‐cell function after the onset of fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Contribution of pancreatic α‐cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Improvement of glycemic control without severe hypoglycemia in a type 1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec
por: Takahashi, Nobuyuki, et al.
Publicado: (2016)

Poorly controlled type 2 diabetes with no progression of diabetes-related complications and low levels of advanced glycation end products: A Case report
por: Nakamura, Tomoka, et al.
Publicado: (2019)

Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study
por: Ueno, Keisuke, et al.
Publicado: (2020)

Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Optimal cardiac strategy based on the history of myocardial infarction in type 2 diabetic patients with coronary artery disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes using non‐steroidal anti‐inflammatory drugs
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Insulinoma Presenting with Reactive Hypoglycemia: Evaluating the Effect of Tumor Resection via Continuous Glucose Monitoring
por: Kikuchi, Tomohiko, et al.
Publicado: (2017)

Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018)

Thiazide Use and Decreased Risk of Heart Failure in Nondiabetic Patients Receiving Intensive Blood Pressure Treatment
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes
por: Nakamura, Tomoka, et al.
Publicado: (2023)

Favourable changes in mortality in people with diabetes: US NHANES 1999–2010
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Obesity, diabetes, and length of time in the United States: Analysis of National Health and Nutrition Examination Survey 1999 to 2012
por: Tsujimoto, Tetsuro, et al.
Publicado: (2016)

Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population‐based observational study
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Intensive Blood Pressure Treatment for Resistant Hypertension: Secondary Analysis of a Randomized Controlled Trial
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

Seasonal Variations of Severe Hypoglycemia in Patients With Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and Non-diabetes Mellitus: Clinical Analysis of 578 Hypoglycemia Cases
por: Tsujimoto, Tetsuro, et al.
Publicado: (2014)

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)
por: Imagawa, Akihisa, et al.
Publicado: (2012)

Case of fulminant type 1 diabetes with coronary microcirculatory dysfunction
por: Yamada, Hodaka, et al.
Publicado: (2014)

Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes
por: Imai, Kenjiro, et al.
Publicado: (2014)

Allogeneic islet transplantation with monitoring of islet‐specific cellular autoimmunity in a Japanese patient with type 1 diabetes: A case report
por: Chujo, Daisuke, et al.
Publicado: (2021)

Evaluation of cellular and humoral autoimmunity before the development of type 1 diabetes in a patient with idiopathic CD4 lymphocytopenia
por: Maruyama, Koji, et al.
Publicado: (2019)

Left Hemiplegia Possibly Due to Glucose Reperfusion Injury after Recovery of Severe Hypoglycemia in a Woman with Type 2 Diabetes Mellitus
por: Sugito, Erika, et al.
Publicado: (2021)

Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study
por: Tsujimoto, Tetsuro, et al.
Publicado: (2011)

Amylase α-2A Autoantibodies: Novel Marker of Autoimmune Pancreatitis and Fulminant Type 1 Diabetes
por: Endo, Toyoshi, et al.
Publicado: (2009)

Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases
por: Inoue, Kaori, et al.
Publicado: (2015)

Graft failure after allogeneic islet transplantation in a patient with type 1 diabetes and a high anti‐glutamic acid decarboxylase antibody titer
por: Kodani, Noriko, et al.
Publicado: (2023)

Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report
por: Terakawa, Aiko, et al.
Publicado: (2020)

Durability of Glucose-Lowering Effect of the First Administration of Dulaglutide: A Retrospective, Single-Center, Single-Arm Study
por: Matsushita, Maya, et al.
Publicado: (2018)

Correlation of glycated albumin but not hemoglobin A(1c) with endogenous insulin secretion in fulminant type 1 diabetes mellitus
por: Koga, Masafumi, et al.
Publicado: (2010)

Fulminant type 1 diabetes mellitus in pregnancy
por: Li, Chun-Yu, et al.
Publicado: (2020)

Fulminant type 1 diabetes developed after influenza split vaccination
por: Sawamura, Toshitaka, et al.
Publicado: (2023)

Diagnostic criteria for acute‐onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus
por: Kawasaki, Eiji, et al.
Publicado: (2014)

Comparing the clinical significance and antigen specificity of insulinoma‐associated antigen‐2 autoantibodies between radioimmunoassay and enzyme‐linked immunosorbent assay in Japanese patients with type 1 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2022)

Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies
por: Tsutsumi, Chiharu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ar1b560i1c7tg3h9e7cffd3m0r